BioCentrury Rounds
Bridging Academia and Industry for Breakthrough Innovation. Join top VCs, academic innovators and biopharma leaders at the inaugural BioCentury Grand Rounds. Examine the latest advances in disease biology, therapeutic modalities and enabling technologies with the experts shaping the future of medicine. Explore cutting-edge science with commercial potential and tackle key translational challenges. Gain industry insights through presentations by emerging biotechs and academic innovators
Conference website
Bridging Academia and Industry for Breakthrough Innovation. Join top VCs, academic innovators and biopharma leaders at the inaugural BioCentury Grand Rounds. Examine the latest advances in disease biology, therapeutic modalities and enabling technologies with the experts shaping the future of medicine. Explore cutting-edge science with commercial potential and tackle key translational challenges. Gain industry insights through presentations by emerging biotechs and academic innovators
Conference website
We are attending this event!
bit.bio offers partnering opportunities that affords access to the most relevant parental human cell types and corresponding disease models. These models are physiologically relevant and highly characterised, offering predictive, in vitro, human cells for early drug discovery, phenotypic screening and high-content imaging applications. Come and meet Kam Dhaliwal, SVP Strategic Alliances to learn more.
Arrange a meeting